 |
Alpine Immune Sciences
ALPN
|
8.94 |
- |
- |
$ 2.17 B |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.79 |
$ 25.38 |
-2.01 % |
$ 1.23 B |
USA |
 |
Arbutus Biopharma Corporation
ABUS
|
24.5 |
$ 4.72 |
1.07 % |
$ 783 M |
Canada |
 |
Aclaris Therapeutics
ACRS
|
8.13 |
$ 3.34 |
-0.6 % |
$ 258 M |
USA |
 |
Acasti Pharma
ACST
|
0.203 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
34 |
- |
-15.15 % |
$ 60.3 M |
Britain |
 |
Ampio Pharmaceuticals
AMPE
|
106 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
Ascendis Pharma A/S
ASND
|
947 |
$ 210.89 |
0.35 % |
$ 5 B |
Danmark |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Albireo Pharma
ALBO
|
13.3 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
Aptorum Group Limited
APM
|
105 |
$ 1.32 |
-0.75 % |
$ 7.2 M |
China |
 |
Alterity Therapeutics Limited
ATHE
|
131 |
$ 3.38 |
-1.17 % |
$ 8.13 B |
Australia |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
AstraZeneca PLC
AZN
|
2.17 |
$ 89.65 |
-0.71 % |
$ 96.9 B |
Britain |
 |
Brickell Biotech
BBI
|
1.42 |
- |
-5.38 % |
$ 6.06 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
5.55 |
- |
-9.72 % |
$ 5.89 M |
USA |
 |
Berkeley Lights
BLI
|
1.49 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Aytu BioScience
AYTU
|
0.237 |
$ 2.31 |
1.5 % |
$ 14.5 M |
USA |
 |
Arena Pharmaceuticals
ARNA
|
105 K |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
Baudax Bio
BXRX
|
0.614 |
- |
0.59 % |
$ 63 K |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
ChromaDex Corporation
CDXC
|
4.32 |
- |
-0.88 % |
$ 598 M |
USA |
 |
Axon Enterprise
AXON
|
19.1 |
$ 566.64 |
-2.48 % |
$ 42.9 B |
USA |
 |
Checkpoint Therapeutics
CKPT
|
3.91 K |
- |
- |
$ 169 M |
USA |
 |
Caladrius Biosciences
CLBS
|
3.58 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Clovis Oncology
CLVS
|
1.55 |
- |
-7.23 % |
$ 13 M |
USA |
 |
Biogen
BIIB
|
2 |
$ 173.98 |
0.86 % |
$ 25.3 B |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
7.34 |
- |
- |
$ 2.18 B |
USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 |
$ 11.4 |
-0.35 % |
$ 737 M |
USA |
 |
Benitec Biopharma
BNTC
|
54.5 |
$ 12.34 |
-4.78 % |
$ 508 M |
USA |
 |
BioNTech SE
BNTX
|
35.7 |
$ 94.71 |
-1.34 % |
$ 27.2 B |
Germany |
 |
Eloxx Pharmaceuticals
ELOX
|
48.8 |
- |
-5.68 % |
$ 8.28 M |
USA |
 |
Acer Therapeutics
ACER
|
25.8 |
- |
2.71 % |
$ 14 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 |
$ 0.28 |
-2.11 % |
$ 609 M |
Israel |
 |
Catalyst Biosciences
CBIO
|
0.296 |
$ 14.84 |
-3.09 % |
$ 977 M |
USA |
 |
Epizyme
EPZM
|
2.74 |
- |
- |
$ 249 M |
USA |
 |
Cerus Corporation
CERS
|
1.49 |
$ 2.16 |
0.47 % |
$ 399 M |
USA |
 |
Acorda Therapeutics
ACOR
|
0.142 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Burford Capital Limited
BUR
|
6.35 |
$ 9.2 |
0.6 % |
$ 1.51 B |
Britain |